TLR4 and androgen insensitivity syndrome: Administration of Schisandrin B, a compound extracted from Schisandra Chinensis, in a rodent rat model of AIS caused a reduction in infarct size and inflammatory mediators, and an improvement in neurological impairments through the downregulation of TLR4 expression in the neocortex [177].